Evidence map›Paper›PMID 33223219›Full record

Observational studyGynecologic oncology2021

COVID-19 free oncologic surgical hub: The experience of reallocation of a gynecologic oncology unit during pandemic outbreak.

Anna M Perrone, Giulia Dondi, Susanna Giunchi, Eugenia De Crescenzo, Safia Boussedra, Marco Tesei, Rocco D'Andrea, Antonio De Leo, Claudio Zamagni, Alessio G Morganti and 2 more

Abstract readObservational Study
In one paragraph

Observational study in Gynecologic oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. ANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO).European heart journal supplements : journal of the European Society of Cardiology · 2021
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anna M PerroneGynecologic Oncology Unit, Azienda Ospedaliero-Universitaria di Bologna, via Albertoni 15, Bologna, Italy; Centro di Studio e Ricerca delle Neoplasie Ginecologiche (CSR), University of Bologna, Bologna, Italy. Electronic address: myriam.perrone@aosp.bo.it.
Giulia DondiGynecologic Oncology Unit, Azienda Ospedaliero-Universitaria di Bologna, via Albertoni 15, Bologna, Italy; Centro di Studio e Ricerca delle Neoplasie Ginecologiche (CSR), University of Bologna, Bologna, Italy.
Susanna GiunchiGynecologic Oncology Unit, Azienda Ospedaliero-Universitaria di Bologna, via Albertoni 15, Bologna, Italy.
Eugenia De CrescenzoGynecologic Oncology Unit, Azienda Ospedaliero-Universitaria di Bologna, via Albertoni 15, Bologna, Italy.
Safia BoussedraGynecologic Oncology Unit, Azienda Ospedaliero-Universitaria di Bologna, via Albertoni 15, Bologna, Italy.
Marco TeseiGynecologic Oncology Unit, Azienda Ospedaliero-Universitaria di Bologna, via Albertoni 15, Bologna, Italy; Centro di Studio e Ricerca delle Neoplasie Ginecologiche (CSR), University of Bologna, Bologna, Italy.
Rocco D'AndreaAnestesiology and Intensive Care Unit, Azienda Ospedaliero-Universitaria di Bologna, via Albertoni 15, Bologna, Italy.
Antonio De LeoCentro di Studio e Ricerca delle Neoplasie Ginecologiche (CSR), University of Bologna, Bologna, Italy; Molecular Diagnostic Unit, Azienda USL, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
Claudio ZamagniCentro di Studio e Ricerca delle Neoplasie Ginecologiche (CSR), University of Bologna, Bologna, Italy; Oncologia Medica Addarii, Azienda Ospedaliero-Universitaria di Bologna, via Albertoni 15, Bologna, Italy.
Alessio G MorgantiCentro di Studio e Ricerca delle Neoplasie Ginecologiche (CSR), University of Bologna, Bologna, Italy; Radiotherapy Unit, Azienda Ospedaliero-Universitaria di Bologna, via Albertoni 15, Bologna, Italy.
Alessandra De PalmaForensic Medicine and Integrated Risk Management Unit, Azienda Ospedaliero-Universitaria di Bologna, via Albertoni 15, Bologna, Italy.
Pierandrea De IacoGynecologic Oncology Unit, Azienda Ospedaliero-Universitaria di Bologna, via Albertoni 15, Bologna, Italy; Centro di Studio e Ricerca delle Neoplasie Ginecologiche (CSR), University of Bologna, Bologna, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDuring the SARS-CoV-2 pandemic, the majority of healthcare resources of the affected Italian regions were allocated to COVID-19 patients. Due to lack of resources and high risk of death, most cancer patients have been shifted to non-surgical treatments. The following reports our experience of a Gynaecologic Oncology Unit's reallocation of resources in a COVID-19 free surgical oncologic hub in order to guarantee standard quality of surgical activities. MATERIALS AND

methodsThis is a prospective observational study performed in the Gynaecologic Oncology Unit, on the outcomes of the reallocation of surgical activities outside the University Hospital of Bologna, Italy, during the Italian lockdown period. Here, we described our COVID-19 free surgical oncologic pathway, in terms of lifestyle restrictions, COVID-19 screening measures, and patient clinical, surgical and follow up outcomes.

resultsDuring the lockdown period (March 9th - May 4th, 2020), 83 patients were scheduled for oncological surgery, 51 patients underwent surgery. Compared to pre-COVID period, we performed the same activities: number of cases scheduled for surgery, type of surgery and surgical and oncological results. No cases of COVID-19 infection were recorded in operated patients and in medical staff. Patients were compliant and well accepted the lifestyle restrictions and reorganization of the care. CONCLUSIONSONCLUSIONS: Our experience showed that the prioritization of oncological surgical care and the allocation of resources during a pandemic in COVID-19 free surgical hubs is an appropriate choice to guarantee oncological protocols.

Indexed as

AdultAgedCOVID-19Disease OutbreaksFemaleGenital Neoplasms, FemaleGynecologic Surgical ProceduresHealth Care RationingHealth Services AccessibilityHospitals, UniversityHumansInfection ControlItalyMiddle AgedPandemicsProspective StudiesAllocation resourcesCOVID-19Gynaecological cancersOvarian cancerPandemicSARS-CoV-2

Identifiers

PMID33223219
PMCPMC7832928

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.